CD274 and liposarcoma: Dedifferentiated liposarcoma (DDLPS) exhibits a relatively higher mutational burden, T cell infiltration and PD-L1 expression, thus becoming the predominant liposarcoma subtype evaluated in clinical trials (9, 10).